Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi, Daniel A. Pollyea, Richard M. Stone, Jessica K. Altman, Gail J. Roboz, Manish R. Patel, Robert Collins, Ian W. Flinn, Mikkael A. Sekeres, Anthony S. Stein, Hagop M. Kantarjian, Ross L. Levine, Paresh Vyas, Kyle J. MacBeth, Alessandra Tosolini, Jason VanOostendorp, Qiang Xu, Ira GuptaThomas Lila, Alberto Risueno, Katharine E. Yen, Bin Wu, Eyal C. Attar, Martin S. Tallman, Stéphane de Botton

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Fingerprint Dive into the research topics of 'Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds